Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.44NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.32NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.1.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDK.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDP.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.31NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.11.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JD.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.13.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.32.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.4.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.86.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.34NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.4.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.8.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.45NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.4.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDRNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.38NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.43.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.29NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.54NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.196NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.57NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.34NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.459NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.117NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.381NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.237NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.382NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.3.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FD.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.44NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.26NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GN.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FW.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.1.2.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBLNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EK.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.466.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Q.1 (Alpha)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.46 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.99 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used